LOBO EV announces definitive agreement with Roundtree Lab

LOBO EV (LOBO) announced the signing of a definitive agreement with Roundtree Lab. Pursuant to the agreement, LOBO will manufacture medical beds, and Roundtree will continue to upgrade these medical beds by integrating an AI system, turning them into AI-drive medical beds. This partnership signifies LOBO’s strategic entry into the burgeoning healthcare equipment market. Building upon the letter of intent announced on January 22, 2025, this definitive agreement solidifies the collaboration between LOBO and Roundtree. The partnership aims to leverage LOBO’s manufacturing capabilities and expertise in connectivity and multimedia interactive systems to bring Roundtree’s patented AI medical bed technology to healthcare facilities across the United States. Key Highlights of the Agreement: LOBO will serve as the exclusive Original Equipment Manufacturer for Roundtree’s medical transfer beds, utilizing Roundtree’s proprietary patents and licenses. Roundtree’s established relationships with U.S. hospitals and healthcare providers will facilitate accelerated market entry and adoption of these advanced medical transfer beds nationwide. LOBO expects that the projected sales arising from the agreement will be $11 million for the first year, $27 million for the second year, and $50 million for the third year. The actual sales revenue depends on the actual orders amount to be placed by Roundtree.